The convergence of CNS and oncology research amplifies the significance of Oncotelic’s recent intellectual property updates for OT-101. Developed in collaboration with Sapu Bioscience, the expanded ...

Teijin Pharma has signed a joint research agreement with Aska Pharmaceutical to develop small-molecule drug candidates for ...

In this episode of Ask the Expert, Susan J. Schniepp, Nelson Labs, and Siegfried Schmitt, Parexel, discuss the benefits of orphan drug development and how a mid-sized company can work with regulators ...

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

President Donald Trump urged Iran to reach a deal through diplomacy and alluded to potential military action if talks fail as he made remarks at the first meeting of his Board of Peace. Follow for ...

The limited supply of this common reagent is set to drive drug prices higher, but there are ways for companies to lessen the impact.

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine policy.

Ace Therapeutics announces its preclinical ophthalmic drug development services to help expedite the discovery of ...

Minimal residual disease (MRD) refers to the small number of myeloma cells that may remain after treatment and are not detectable using conventional response criteria. In multiple myeloma, MRD ...

Nottingham, England Wednesday, February 18, 2026, 17:00 Hrs [IST] ...